Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Announces Investigation of Accelerate Diagnostics, Inc. (AXDX)
Holzer & Holzer, LLC is investigating Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for potential violations of federal securities laws. This follows the Company's announcement on October 21, 2022, indicating that the FDA mandated 510(k) clearance for its Accelerate Arc Products, leading to the discontinuation of marketing and distribution in the US. As a result, the stock price of AXDX has significantly dropped. Investors are encouraged to contact the firm if they incurred losses.
- None.
- Stock price declined after FDA announcement requiring 510(k) clearance.
- Discontinuation of US marketing and distribution for Accelerate Arc Products.
ATLANTA, GA / ACCESSWIRE / October 27, 2022 / Holzer & Holzer, LLC is investigating whether Accelerate Diagnostics, Inc. ("Accelerate Diagnostics" or the "Company") (NASDAQ:AXDX) complied with federal securities laws. On October 21, 2022, Accelerate Diagnostics announced that it was required by the FDA to obtain 510(k) clearance for its Accelerate Arc Products, discontinue US marketing and distribution of those products, and revise/remove the Company's registration and listing of those products as Class I devices. Following this announcement, the Company's stock price dropped.
If you purchased Accelerate Diagnostics stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/accelerate-diagnostics/ to discuss your legal rights.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
SOURCE: Holzer & Holzer
View source version on accesswire.com:
https://www.accesswire.com/722795/Nationally-Ranked-Investors-Rights-Firm-Holzer-Holzer-LLC-Announces-Investigation-of-Accelerate-Diagnostics-Inc-AXDX
FAQ
What did the FDA require from Accelerate Diagnostics (AXDX)?
Why did the stock price of AXDX drop?
Who is investigating Accelerate Diagnostics (AXDX)?
What should investors do if they lost money on AXDX?
